Constellation Pharmaceuticals, Inc. CNST
Set alert
33.99 +33.99 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 1.63B
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -8.83
- Beta
- 2.58
- Short ratio
- 0.76
- Inst. own
- 109.70%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 4, 2021
- 50-d avg
- 33.82
- 200-d avg
- 28.33
- 1y target
- 40.71
Analyst view
Consensus: hold
Hold
Price target (mean) 40.71 +19.8% upside
Now 33.99
- Target (low)
- 34.00
- Target (mean)
- 40.71
- Target (high)
- 75.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy2
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 11
- 2 months ago 11
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.88 | -0.94 – -0.84 | -0.70 | -25.7% | 0 | 0.0% | 10 |
| Next quarter | -0.91 | -0.95 – -0.86 | -0.71 | -28.2% | 0 | 0.0% | 10 |
| Current year | -3.55 | -3.70 – -3.37 | -2.81 | -26.3% | 0 | 0.0% | 10 |
| Next year | -3.85 | -4.43 – -3.43 | -3.55 | -8.5% | 2.31M | 0.0% | 10 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 17, 2021 | RBC Capital | Downgrade | Outperform | Sector Perform |
| Jun 4, 2021 | Jefferies | Downgrade | Buy | Hold |
| Jun 3, 2021 | Truist Securities | Downgrade | Buy | Hold |
| Jun 3, 2021 | Cowen & Co. | Downgrade | Outperform | Market Perform |
| Jan 25, 2021 | BMO Capital | Upgrade | Market Perform | Outperform |
| Sep 8, 2020 | Oppenheimer | Downgrade | Outperform | Perform |
| Sep 3, 2020 | Brookline Capital | Initiated | — | Buy |
| Aug 6, 2020 | BMO Capital | Maintained | — | Market Perform |
| Jul 20, 2020 | Jefferies | Maintained | — | Buy |
| Jun 24, 2020 | JMP Securities | Initiated | — | Market Perform |
| Jun 15, 2020 | BMO Capital | Maintained | — | Market Perform |
| May 7, 2020 | H.C. Wainwright | Reiterated | — | Buy |
| Mar 11, 2020 | Baird | Maintained | — | Outperform |
| Feb 13, 2020 | SunTrust Robinson Humphrey | Initiated | — | Buy |
| Feb 7, 2020 | Cowen & Co. | Initiated | — | Outperform |
| Dec 10, 2019 | Baird | Reiterated | — | Outperform |
| Nov 7, 2019 | BMO Capital | Maintained | — | Outperform |
| Nov 7, 2019 | Baird | Maintained | — | Outperform |
| Nov 7, 2019 | H.C. Wainwright | Reiterated | — | Buy |
| Sep 4, 2019 | RBC Capital | Initiated | — | Outperform |
| Apr 2, 2019 | Oppenheimer | Maintained | Outperform | Outperform |
| Jan 29, 2019 | Baird | Initiated | — | Outperform |
| Dec 20, 2018 | H.C. Wainwright | Initiated | — | Buy |
| Aug 13, 2018 | JP Morgan | Initiated | — | Overweight |
| Aug 13, 2018 | BMO Capital | Initiated | — | Outperform |
| Aug 13, 2018 | Oppenheimer | Initiated | — | Outperform |